Bempedoic acid: Completed Ph III CLEAR Harmony (1002-040) enrollment

Esperion completed enrollment of about 2,000 patients at high cardiovascular risk and whose LDL-C is not adequately controlled with statins in the double-blind, placebo-controlled, international Phase...